Results 101 to 110 of about 61,025 (285)

Pulmonary alveolar proteinosis: diagnosis using routinely processed smears of bronchoalveolar lavage fluid. [PDF]

open access: yes, 1997
AIMS: For the diagnosis of pulmonary alveolar proteinosis from bronchoalveolar lavage specimens it is normally necessary to make an ultrastructural examination.
I Okayasu   +3 more
core   +2 more sources

Aggressive Head and Neck Squamous Cell Carcinoma in the Setting of GATA2 Deficiency

open access: yesHead &Neck, Volume 47, Issue 7, Page E82-E86, July 2025.
ABSTRACT Background GATA2 deficiency is a rare genetic disorder associated with hematologic, infectious, and neoplastic complications. We report a case of a patient with GATA2 deficiency who developed aggressive squamous cell carcinoma (SCC) of the head and neck, an atypical manifestation of this condition.
Brejjette Aljabi   +3 more
wiley   +1 more source

Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up

open access: yesOrphanet Journal of Rare Diseases, 2020
Background Treatment of autoimmune pulmonary alveolar proteinosis (aPAP) by inhaled granulocyte-macrophage colony stimulating factor (GM-CSF) is considered safe and effective.
X. Tian   +14 more
semanticscholar   +1 more source

Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework [PDF]

open access: yes, 2017
Background The accumulation of MWCNTs in the lung environment leads to inflammation and the development of disease similar to pulmonary fibrosis in rodents.
Banville, Allyson   +8 more
core   +1 more source

Silicosis Mimicking Lung Malignancy: A Case Series

open access: yesRespirology Case Reports, Volume 13, Issue 7, July 2025.
This case series describes three patients that were suspected to have a primary lung malignancy based on FDG‐PET findings, but were found to have pulmonary silicosis. With this series, we demonstrate how histologic examination can differentiate between silicosis and malignancy and provide suggestions to help clinicians differentiate between these two ...
Titia van Duin   +4 more
wiley   +1 more source

Imatinib-induced interstitial pneumonitis – a literature review and case report [PDF]

open access: yes, 2020
Imatinib is generally well tolerated, with mild common side effects such as nausea and vomiting, diarrhea, muscle cramps, fatigue, skin rash and edema; however, pulmonary complications are uncommon. A 73-year-old woman undergoing one month treatment with
Ciulei, George   +12 more
core   +2 more sources

Telomere Shortening in Interstitial Lung Disease: Challenges and Promises

open access: yesThe Clinical Respiratory Journal, Volume 19, Issue 7, July 2025.
Telomerase abnormalities such as related gene mutations lead to decrease in telomerase activity and telomere shortening. Individual cells undergoing continuous division exhibit telomere shortening. A successive shortening of the telomere results in dysfunctional telomeres.
Haonan Jin   +8 more
wiley   +1 more source

Autoimmune pulmonary alveolar proteinosis developed during immunosuppressive treatment in polymyositis with interstitial lung disease: a case report

open access: yesBMC Pulmonary Medicine, 2020
Background Pulmonary alveolar proteinosis (PAP) is characterized by the accumulation of surfactant proteins within the alveolar spaces. Autoimmune PAP (APAP) caused by elevated levels of GM-CSF autoantibodies (GM-Ab) is very rarely associated with ...
Shintaro Sato   +13 more
semanticscholar   +1 more source

Lung Lavage Cell Profiles in Diffuse Lung Disease [PDF]

open access: yes, 2010
The standard armamentarium of tests that are used by pulmonologist are laboratory tests, pulmonary function tests, different radiological techniques (conventional chest-X rays, HRCT scans, etc) and pathohistological analyses of biopsies.
Silvana Smojver-Ježek   +1 more
core   +1 more source

Pulmonary alveolar proteinosis: a rare pulmonary toxicity of sirolimus. [PDF]

open access: yes, 2007
Transpl Int. 2007 Mar;20(3):291-6. Pulmonary alveolar proteinosis: a rare pulmonary toxicity of sirolimus. Pedroso SL, Martins LS, Sousa S, Reis A, Dias L, Henriques AC, Sarmento AM, Cabrita A.
CABRITA, A.   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy